HOMEPAGE
Fully Diluted Subscribe

Nasdaq · Biotech stocks database

ICLR — ICON plc

ICLR (ICON plc) stock: $204.74, $15.68B market cap, $538.8M cash, $18.94B EV, $16.11B fully diluted market cap. Data from Fully Diluted's biotech stocks database.

What they do

We offer a full range of clinical, consulting and commercial services that range from clinical development strategy, planning and trial design, to full study execution, and post-market commercialization. ICON provides its services across a range of clinical outsourcing operating models including strategic partnerships, preferred provider, full-service delivery to functional service provision and stand-alone services.

Source: 20-F FY2025 via SEC EDGAR

Share price
$204.74
Market cap
$15,676.4M
Cash
$538.8M
Enterprise value
$18,943.8M

Balance sheet

Cash$538.8M
Debt$3,806.2M
Net cash-$3,267.4M
Enterprise value$18,943.8M
Basic shares76.6M shares
Fully diluted shares78.7M shares
Fully diluted market cap$16,112.9M
Cash per share$7.04
Quarterly burn+$281.3M generated

Cash figures as of 2025-12-31. Database snapshot: 2026-11-07.

Share structure

Common
76.6M
Pre-funded warrants
0.0M
Options
0.6M
RSUs
1.5M
Warrants
0.0M
Converts
0.0M
Conv preferred
0.0M
ESPP reserve
—
FDSO
78.7M

Cap table as of 2025-12-31.

Price history

Loading ICLR daily closes…

Loading price history…

Next catalyst

Jynneos · Jan 11 - Feb 22 in 9 wks · Phase 2 · Monkeypox (Mpox)

Get the weekly biotech catalyst rundown.
Cash runways, financings, and trial readouts for all 721 stocks.
Subscribe to Compounding Ego